Federal contractor · ROCKVILLE, MD

SANARIA INC.

No contract obligations recorded for SANARIA INC. in FY2026. Since FY2017: $12.9M. It also received $2M in federal grants and other assistance in FY2026.

Obligations · FY2026
$0
New awards
0
Sole-source
—
Single offer
—
UEI
YLF2SS2NYGC5
Small businessVeteran-owned
Open in the contracts explorerRelationship graph

Spending by fiscal year

Obligations per federal fiscal year (October–September).

  1. 4.9MFY2017
  2. 4MFY2018
  3. 3.2MFY2019
  4. 98.3KFY2020
  5. 0FY2021
  6. 642.1KFY2022
  7. 89.1KFY2023
  8. -26.5KFY2024

Top buying agencies

Obligations in FY2026.

No contract obligations recorded for SANARIA INC. in FY2026.

What was bought · Where the work was performed

Obligations in FY2026.

What was bought

Where the work was performed

Integrity signals

Shares of the year's obligations, next to the country's.

Federal grants & assistance received

Grants, loans (counted at their subsidy cost), direct payments and insurance, by fiscal year of the action (USAspending.gov, FABS). Reported apart from contracts and never added to them.

SANARIA INC. received $2M in federal assistance in FY2026, on 10 actions (1 new awards), −59% vs FY2025. Its largest program was 93.855 · Allergy and Infectious Diseases Research ($2M).

Assistance · FY2026
$2M
New awards
1
Actions
10
Since FY2021
$41M

Assistance by fiscal year

  1. 8.9MFY2021
  2. 10.6MFY2022
  3. 8MFY2023
  4. 6.6MFY2024
  5. 4.9MFY2025
  6. 2MFY2026

By type

  1. Grants$2M100%

Top programs

  1. 93.855 · Allergy and Infectious Diseases Research$2M100%

Awarding agencies

  1. National Institutes of Health$2M100%
    Department of Health and Human Services

Largest awards

  1. EXPANDING THE BREADTH, MAGNITUDE, AND DURABILITY OF PFSPZ VACCINES BY CREATING MULTI-STRAIN VACCINES, DESIGNER HYBRID AND GENETICALLY…$5.9M
    93.855 · Allergy and Infectious Diseases Research· National Institutes of Health· Cooperative agreement· Apr 8, 2021 – Jan 15, 2026· U01AI155356
  2. IN-VITRO CULTURE OF PLASMODIUM FALCIPARUM SPOROZOITES FOR MALARIA VACCINE$5.9M
    93.855 · Allergy and Infectious Diseases Research· National Institutes of Health· Project grant· Apr 9, 2021 – Jan 20, 2026· R44AI085740
  3. DEVELOPMENT OF NON-HUMAN PRIMATE MODELS TO ASSESS IMMUNOLOGICAL MECHANISMS AND ANTIGENIC TARGETS OF PROTECTIVE SPOROZOITE (SPZ) VACCINES…$4.7M
    93.855 · Allergy and Infectious Diseases Research· National Institutes of Health· Cooperative agreement· Apr 1, 2021 – Jan 15, 2026· U01AI155354
  4. MANUFACTURE OF ASEPTIC, PURIFIED, CRYOPRESERVED PLASMODIUM VIVAX SPOROZOITES - ABSTRACT PLASMODIUM VIVAX (PV) MALARIA IS SECOND TO P…$3M
    93.855 · Allergy and Infectious Diseases Research· National Institutes of Health· Cooperative agreement· Aug 1, 2024 – Sep 17, 2026· U44AI124867
  5. A GENETICALLY MODIFIED PLASMODIUM FALCIPARUM SPOROZOITE VACCINE ATTENUATED AT THE LATE-LIVER STAGE - ABSTRACT IN 2020 MALARIA CAUSED 241M…$3M
    93.855 · Allergy and Infectious Diseases Research· National Institutes of Health· Project grant· Mar 7, 2023 – Aug 11, 2026· R44AI149927
  6. PROGRESSING PFSPZ VACCINES FOR MALARIA TO LICENSURE AND COMMERCIALIZATION - ABSTRACT SANARIA’S MISSION IS THE LICENSURE AND MARKETING OF…$3M
    93.855 · Allergy and Infectious Diseases Research· National Institutes of Health· Project grant· Apr 14, 2023 – Jan 15, 2026· SB1AI174403

Source: Federal financial assistance transactions (Financial Assistance Broker Submission) (U.S. Department of the Treasury, USAspending.gov), data current to Oct 8, 2026, loaded Oct 8, 2026 · FY2021–FY2026.

Subawards

Matched by Unique Entity ID: the first-tier subawards this organization reported as a prime recipient, and those primes reported paying it.

As a prime: who it pays · FY2026

No subawards reported as a prime in FY2026.

As a sub-recipient: who pays it · FY2026

  • Sub-grants: $174.5K (2 subawards)

2 primes

  1. SEATTLE CHILDREN'S HOSPITAL$92.6K53%
    SEATTLE, WA · 1 subaward
  2. EMORY UNIVERSITY$81.9K47%
    ATLANTA, GA · 1 subaward

By fiscal year

  • FY2021: $0 paid out · $50K received
  • FY2022: $0 paid out · $47.2K received
  • FY2023: $0 paid out · $604.8K received
  • FY2025: $0 paid out · $340.9K received
  • FY2026: $0 paid out · $174.5K received

Primes report first-tier subawards of $30,000 or more themselves, and many go unreported (GAO-24-106214). Reporting moved from FSRS to SAM.gov in March 2025 and fewer sub-contracts have been reported since. Amounts are what primes reported; they are never added to prime award totals.

Source: Subawards (first-tier sub-contracts and sub-grants reported under FFATA) (U.S. Department of the Treasury, USAspending.gov (reports filed in SAM.gov, formerly FSRS)), data current to Oct 8, 2026, loaded Oct 8, 2026 · Subawards loaded from FY2021.

Teaming partners

Companies this company reported paying, primes that reported paying it, from FFATA subaward reports.

Companies it pays

No subawards reported to other companies.

Primes that pay it

5 companies · $1.2M reported

  1. SEATTLE CHILDREN'S HOSPITAL$650.1K
    SEATTLE, WA · 2 subawards
  2. THE HENRY M. JACKSON FOUNDATION FOR THE ADVANCEMENT OF MILITARY MEDICINE, INC.$300.4K
    BETHESDA, MD · 1 subaward
  3. UNIVERSITY OF WASHINGTON$144.5K
    SEATTLE, WA · 3 subawards

Showing the top 3 of each list. Open the profile for potential partners and the full lists.

Primes report first-tier subawards of $30,000 or more themselves, and many go unreported (GAO-24-106214). Reporting moved from FSRS to SAM.gov in March 2025 and fewer sub-contracts have been reported since. Amounts are what primes reported; they are never added to prime award totals.

Source: Subawards (first-tier sub-contracts and sub-grants reported under FFATA) (U.S. Department of the Treasury, USAspending.gov (reports filed in SAM.gov, formerly FSRS)), data current to Oct 8, 2026, loaded Oct 8, 2026 · Subawards loaded from 2021.

Source: Federal contract transactions (Federal Procurement Data System) (U.S. Department of the Treasury, USAspending.gov), data current to Oct 7, 2026, loaded Oct 7, 2026.